Faculty: Aaron Katz, Abhinav Sidana, Daniel Rukstalis

Moderator: Tom Polascik

Aaron E. Katz, MD, FACS

Aaron E. Katz, MD is currently the Chairman of Urology at NYU Langone Hospital—Long Island and Professor of Urology in the NYU Long Island School of Medicine. Dr. Katz established, and continues to serve as the Program Director of the Urology Residency Program under NYU Long Island School of Medicine. Dr. Katz is also a Urology attending physician in a progressive Urology practice with offices in Garden City, Long Island and the upper east side of Manhattan. Prior to joining NYU Langone Hospital—Long Island, he was a Professor of Urology at Columbia University Hospital College of Physicians and Surgeons and was the Director of the Center for Holistic Urology, a Center which he established in 1998 performing basic research and clinical trials that investigated the role of natural therapies within Urology. Dr. Katz currently serves as the Principle Investigator for numerous clinical trials. He has received several awards and grants to further his research. After graduating from New York Medical College in 1986, Dr. Katz completed a six-year training program in Brooklyn at the Maimonides Medical Center. Following the completion of his residency, he was awarded a Ferdinand Valentine Fellowship from the New York Academy of Medicine to further his studies in Urologic Oncology at Columbia University. He offers the best of complementary and integrative medicine to patients seeking healthy, holistic, and multidisciplinary approaches to treat prostate cancer and maintain wellness. Dr. Katz is also recognized as an expert in the field of prostate cryosurgery. In the early 1990's, he began using cryosurgery to treat and cure prostate cancers. His pioneer work in advancing the technology helped Medicare approve of this therapy for treating radiation- recurrent tumors. Dr. Katz has trained over 100 Urologists internationally to perform cryosurgery in their hospitals. Dr. Katz has published over 150 scientific articles in peer- reviewed journals, and has written 5 chapters for Urologic textbooks.

Abhinav Sidana, MD

Abhinav Sidana, MD is an Assistant Professor and Director of Urologic Oncology in the Division of Urology at University of Cincinnati Medical Center. His clinical practice includes both surgical and non-operative management of prostate, kidney, ureteral, testicular, and bladder cancers.  Dr. Sidana is actively involved in urologic cancer research and his interests include functional prostate imaging, image-guided and focal treatments for prostate cancer and clinical trials on novel treatments for urologic cancers. Dr Sidana is the Course Director for Frontiers in Oncologic Prostate Care and Ablative Local Therapy (FOCAL) meeting aimed to provide both the theoretical and hands on training to the urologists interested in incorporating focal therapy as a management option for their patients. He also serves on the Research Committee for the International Focal Therapy Society and is leading the efforts to develop an international multi-institutional prospective registry for patients undergoing ablative therapy for prostate cancer.

Daniel Rukstalis, M.D.

Daniel Rukstalis, M.D., is currently a member of the Division of Urology at Prisma Health Midlands Health system with an ongoing focus on advanced urologic imaging and targeted tissue biopsy and ablation. He has been active in the development and investigation of new devices for the management of urologic disorders including malignancy and BPH. He has long served as a member of the AUA ultrasound educational faculty and participated in the publication of the AUA policy on MRI imaging for the diagnosis and management of prostatic adenocarcinoma.  He has served as Residency Program Director in the Geisinger Health System as well as Wake Forest University Department of Urology and continues to be active in the education of genitourinary surgeons. 

Thomas J. Polascik, MD FACS

Thomas J. Polascik, MD FACS is Professor of Surgery, Duke University Medical Center. He is the Director of Surgical Technology, Duke Prostate and Urological Cancer Center. He is the founder and co-director of the International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer that began at Duke in 2008. Dr Polascik is the Editor of the text Imaging and Focal Therapy of Early Prostate Cancer. He currently is the founder and President of the Focal Therapy Society, Duke’s Director of the Society of Urologic Oncology fellowship training program and the Genitourinary Program on Focal Therapy at the Duke Cancer Institute.  He is the Medical Director of Duke Men’s Health Initiative Screening event each September and is a governing member of several medical boards and societies. His clinical and research interests focus on prostate and kidney cancer. He has authored over 350 peer-reviewed manuscripts and book chapters.